Fain's most recent trade in Orchestra BioMed Holdings Inc was a trade of 5,760 Common Stock, par value $0.0001 per share done at an average price of $2.6 . Disclosure was reported to the exchange on Aug. 25, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 25 Aug 2025 | 5,760 | 71,709 | - | 2.6 | 15,034 | Common Stock, par value $0.0001 per share |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 7,500 | 7,500 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 7,500 | 58,449 | - | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 311.30 per share. | 06 Aug 2025 | 8,980 | 150,326 (0%) | 0% | 311.3 | 2,795,474 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 310.65 per share. | 06 Aug 2025 | 6,985 | 159,306 (0%) | 0% | 310.6 | 2,169,890 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 312.06 per share. | 06 Aug 2025 | 35 | 150,291 (0%) | 0% | 312.1 | 10,922 | Common Stock |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 3.05 per share. | 26 Jun 2025 | 2,683 | 50,949 | - | 3.0 | 8,183 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 36,797 | 36,797 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 12,422 | 53,632 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 14,492 | 14,492 | - | - | Restricted Share Units | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 97,909 (0%) | 0% | - | Ordinary Shares | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 9,632 | 0 | - | - | Restricted Share Units | |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 870 | 166,291 (0%) | 0% | 0 | Common Stock | |
CubeSmart | John W. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 2,956 | 44,834 (0%) | 0% | 0 | Common | |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 252.96 per share. | 19 May 2025 | 15,773 | 169,248 (0%) | 0% | 253.0 | 3,989,938 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 253.66 per share. | 19 May 2025 | 3,827 | 165,421 (0%) | 0% | 253.7 | 970,757 | Common Stock |
Orrstown Financial Service... | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,500 | 2,500 (0%) | 0% | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
Ceva Inc | Amir Faintuch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 6,198 | 10,022 (0%) | 0% | 0 | Common Stock | |
Orrstown Financial Service... | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 31.15 per share. | 24 Mar 2025 | 1,000 | 11,396 (0%) | 0% | 31.2 | 31,150 | Orrstown Financial Services, Inc, Common Stock |
Orrstown Financial Service... | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 31.19 per share. | 24 Mar 2025 | 1,000 | 13,396 (0%) | 0% | 31.2 | 31,190 | Orrstown Financial Services, Inc, Common Stock |
Orrstown Financial Service... | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 31.18 per share. | 24 Mar 2025 | 1,000 | 12,396 (0%) | 0% | 31.2 | 31,180 | Orrstown Financial Services, Inc, Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 256.64 per share. | 13 Feb 2025 | 17,817 | 186,704 (0%) | 0% | 256.6 | 4,572,555 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 257.15 per share. | 13 Feb 2025 | 1,683 | 185,021 (0%) | 0% | 257.1 | 432,783 | Common Stock |
Orrstown Financial Service... | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 1,000 | 1,000 (0%) | 0% | 0 | Orrstown Financial Services, Inc. Common, Restricted Stock | |
Ceva Inc | Amir Faintuch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 3,824 | 3,824 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 210.02 per share. | 30 Oct 2024 | 25,000 | 204,521 (0%) | 0% | 210.0 | 5,250,500 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 206.64 per share. | 30 Oct 2024 | 18,900 | 5,500 (0%) | 0% | 206.6 | 3,905,496 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Sep 2024 | 286,146 | 0 (0%) | 0% | 0 | Common Stock | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.64 per share. | 06 Sep 2024 | 2,000 | 44,810 | - | 5.6 | 11,280 | Common Stock, par value $0.0001 per share ("Common Stock") |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.34 per share. | 06 Sep 2024 | 1,800 | 41,210 | - | 5.3 | 9,612 | Common Stock |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 06 Sep 2024 | 1,800 | 43,010 | - | 5.4 | 9,774 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 156.25 per share. | 30 Jul 2024 | 19,338 | 159,779 (0%) | 0% | 156.3 | 3,021,563 | Common Stock |
Orrstown Financial Service... | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 10,396 | 10,396 (0%) | 0% | 0 | Orrstown Financial Services, Inc, Common Stock | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 17,068 | 17,068 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 5,376 | 46,810 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 88,277 (0%) | 0% | - | Ordinary Shares | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 21,108 | 0 | - | - | Restricted Share Units | |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 21.58 per share. | 14 Jun 2024 | 695 | 11,882 (0%) | 0% | 21.6 | 14,998 | Common stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Sale of securities on an exchange or to another person at price $ 153.96 per share. | 13 Jun 2024 | 19,584 | 179,117 (0%) | 0% | 154.0 | 3,015,153 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jun 2024 | 9,034 | 70,247 (0%) | 0% | 0 | Common Stock | |
Teva Pharmaceutical Industries | Ronit Satchi-Fainaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 9,632 | 9,632 | - | - | Restricted Share Units | |
CubeSmart | John W. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,832 | 41,878 (0%) | 0% | 0 | Common | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 20,000 | 0 | - | - | Stock Options | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.71 per share. | 17 Apr 2024 | 7,179 | 137,809 (0%) | 0% | 5.7 | 40,974 | Common Stock; $.10 par value |
Royal Caribbean Cruises | Richard D. Fain | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.77 per share. | 24 Mar 2024 | 47,882 | 198,701 (0%) | 0% | 135.8 | 6,500,939 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 22.60 per share. | 12 Mar 2024 | 1,327 | 11,187 (0%) | 0% | 22.6 | 29,990 | Common Stock |
Royal Caribbean Cruises | Fain Richard D. | Director | Sale of securities on an exchange or to another person at price $ 123.14 per share. | 27 Feb 2024 | 8,160 | 246,583 (0%) | 0% | 123.1 | 1,004,822 | Common Stock |
Ultralife Corp | Fain Philip A. | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2023 | 18,400 | 143,400 | - | - | Stock Options for ULBI Common Stock; $.10 par Value | |
Royal Caribbean Cruises | D. Fain Richard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 124,330 | 252,371 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Fain D. Richard | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Dec 2023 | 6,144 | 79,281 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 2,372 | 254,743 (0%) | 0% | 0 | Common Stock | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2023 | 11,667 | 41,434 | - | 0 | Common Stock, par value $0.0001 per share ("Common Stock") | |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 19.65 per share. | 23 Jun 2023 | 2,500 | 8,761 (0%) | 0% | 19.7 | 49,125 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 19.68 per share. | 23 Jun 2023 | 1,000 | 9,761 (0%) | 0% | 19.7 | 19,680 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 19.65 per share. | 23 Jun 2023 | 99 | 9,860 (0%) | 0% | 19.6 | 1,945 | Common Stock |
PRA Group Inc | John H. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 6,548 | 42,445 (0%) | 0% | 0 | Common Stock | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 20,000 | 0 | - | - | Stock Options | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.29 per share. | 23 May 2023 | 630 | 130,630 (0%) | 0% | 4.3 | 2,703 | Common Stock; $.10 par value |
CubeSmart | John W. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 2,601 | 39,046 (0%) | 0% | 0 | Common | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2023 | 2,906 | 0 | - | - | Warrant (Right to Buy) | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 10 May 2023 | 2,906 | 29,767 | - | 1.1 | 3,138 | Common Stock, par value $0.0001 per share ("Common Stock") |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Grant, award, or other acquisition of securities at price $ 23.78 per share. | 10 Mar 2023 | 1,261 | 6,261 (0%) | 0% | 23.8 | 29,987 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2023 | 26,797 | 132,182 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.12 per share. | 20 Feb 2023 | 8,604 | 123,578 (0%) | 0% | 73.1 | 629,124 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 2,682 | 105,385 (0%) | 0% | 0 | Common Stock | |
Orchestra BioMed Holdings Inc | Eric S. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 23,250 | 23,250 | - | - | Nonstatutory Stock Option (Right to Buy) | |
Royal Caribbean Cruises | Richard D. Fain | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 20,000 | 548,479 (0%) | 0% | 0 | Common Stock | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 3.99 per share. | 07 Dec 2022 | 1,500 | 130,000 (0%) | 0% | 4.0 | 5,985 | Common Stock; $.10 par value |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 20.35 per share. | 22 Aug 2022 | 1,650 | 4,900 (0%) | 0% | 20.4 | 33,578 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 10 Aug 2022 | 2,000 | 3,100 (0%) | 0% | 20.5 | 41,000 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 10 Aug 2022 | 1,000 | 1,100 (0%) | 0% | 20.5 | 20,500 | Common Stock |
Codorus Valley Bancorp Inc | Scott V. Fainor | Director | Purchase of securities on an exchange or from another person at price $ 20.30 per share. | 10 Aug 2022 | 150 | 3,250 (0%) | 0% | 20.3 | 3,045 | Common Stock |
PRA Group Inc | John H. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 4,197 | 35,897 (0%) | 0% | 0 | Common Stock | |
CubeSmart | John W. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 2,438 | 36,445 (0%) | 0% | 0 | Common | |
Royal Caribbean Cruises | Richard D. Fain | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.99 per share. | 24 Mar 2022 | 13,046 | 568,479 (0%) | 0% | 76.0 | 991,398 | Common Stock |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 30,000 | 0 | - | - | Stock Options | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.71 per share. | 02 Mar 2022 | 8,500 | 128,500 (0%) | 0% | 3.7 | 31,538 | Common Stock; $.10 par value |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 2,256 | 581,525 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 50,020 | 597,258 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.80 per share. | 07 Feb 2022 | 17,989 | 579,269 (0%) | 0% | 79.8 | 1,435,522 | Common Stock |
PRA Group Inc | John H. Fain | Director | Sale of securities on an exchange or to another person at price $ 49.37 per share. | 28 Dec 2021 | 2,754 | 35,300 (0%) | 0% | 49.4 | 135,965 | Common Stock |
PRA Group Inc | John H. Fain | Director | Sale of securities on an exchange or to another person at price $ 49.70 per share. | 28 Dec 2021 | 1,200 | 34,100 (0%) | 0% | 49.7 | 59,640 | Common Stock |
PRA Group Inc | John H. Fain | Director | Sale of securities on an exchange or to another person at price $ 48.11 per share. | 23 Dec 2021 | 2,169 | 38,054 (0%) | 0% | 48.1 | 104,351 | Common Stock |
PRA Group Inc | John H. Fain | Director | Sale of securities on an exchange or to another person at price $ 48.38 per share. | 23 Dec 2021 | 1,975 | 40,223 (0%) | 0% | 48.4 | 95,551 | Common Stock |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 16 Dec 2021 | 906 | 120,000 (0%) | 0% | 5.5 | 4,939 | Common Stock; $.10 par value |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 16 Dec 2021 | 634 | 119,094 (0%) | 0% | 5.5 | 3,456 | Common Stock; $.10 par value |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.45 per share. | 16 Dec 2021 | 300 | 118,460 (0%) | 0% | 5.5 | 1,636 | Common Stock; $.10 par value |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2021 | 20,000 | 20,000 | - | - | Common Stock (Right to Buy) | |
PRA Group Inc | John H. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,647 | 42,198 (0%) | 0% | 0 | Common Stock | |
CubeSmart | John W. Fain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 2,452 | 34,007 (0%) | 0% | 0 | Common | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 70,000 | 0 | - | - | Stock Options | |
Ultralife Corp | Philip A. Fain | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.94 per share. | 01 Mar 2021 | 23,160 | 118,160 (0%) | 0% | 3.9 | 91,213 | Common Stock; $.10 par value |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.12 per share. | 20 Feb 2021 | 10,042 | 758,002 (0%) | 0% | 78.1 | 784,431 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 37,513 | 0 | - | - | Stock Option (Right to Buy) | |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.18 per share. | 15 Jan 2021 | 37,513 | 808,032 (0%) | 0% | 46.2 | 1,732,350 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.58 per share. | 15 Jan 2021 | 26,999 | 781,033 (0%) | 0% | 74.6 | 2,013,585 | Common Stock |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Other type of transaction at price $ 0.00 per share. | 14 Dec 2020 | 67,782 | 790,923 (0%) | 0% | - | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2020 | 10,404 | 770,519 (0%) | 0% | 0 | Common Stock | |
Royal Caribbean Cruises | Richard D. Fain | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2020 | 10,000 | 780,923 (0%) | 0% | 0 | Common Stock |